(S)-tert-Butyl(1-(5-(4-bromophenyl)-1H-imidazol-2-yl)-2-methylpropyl)carbamate
98%
- Product Code: 237810
CAS:
1087346-51-7
| Molecular Weight: | 394.31 g./mol | Molecular Formula: | C₁₈H₂₄BrN₃O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature |
Product Description:
Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports selective binding to enzyme active sites, making it valuable in creating targeted therapies. Commonly employed in medicinal chemistry for optimizing drug potency and metabolic stability during lead compound refinement.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 100mg | 10-20 days | £149.44 |
+
-
|
| 250mg | 10-20 days | £248.83 |
+
-
|
| 1g | 10-20 days | £523.37 |
+
-
|
(S)-tert-Butyl(1-(5-(4-bromophenyl)-1H-imidazol-2-yl)-2-methylpropyl)carbamate
Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports selective binding to enzyme active sites, making it valuable in creating targeted therapies. Commonly employed in medicinal chemistry for optimizing drug potency and metabolic stability during lead compound refinement.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
£0.00
£0.00
Total :